Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta

NCT07108153 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis (CF)

Interventions

DRUG: SION-719
DRUG: Placebo-to-match SION-719

Sponsor

Sionna Therapeutics Inc.